CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Southwest Phamaceutical Company Snapshot
Business Description:
Southwest Phamaceutical operates in the Pharmaceutical preparations sector. Southwest Pharmaceutical Co., Ltd. is principally engaged in the manufacture and distribution of chemical drug preparations. The Company provides injections, powders, tablets, infusion drugs, tinctures, mixtures and frozen-dry drugs, among others. The Company's major products include compound paracetamol tablets, ibuprofen controlled-release tablets, ceftizoxime sodium for injection and morphine hydrochloride sustained-release tablets, among others. It distributes its products primarily in domestic market, with Southwest China as its major market. In our complete report available for purchase the company is compared to: Qinghai Gelatin Co., Ltd., Zhejiang Hisoar Pharmaceutical Co. Ltd and China Medical System Holdings Limited.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Southwest Phamaceutical
  Stock Performance Chart for Southwest Phamaceutical
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): 7.10
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 5.5%  
4 Weeks -18.8%   52 Weeks 3.4%  
 
Southwest Phamaceutical Key Data:
  Ticker: 600666 Country: CHINA
  Exchanges: SHG Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2010 Sales 853,222,000
(Year Ending Jan 2011).
Employees: 1,625
  Currency: Chinese Renmimbi Market Cap: 2,060,038,716
  Fiscal Yr Ends: December Shares Outstanding: 290,146,298
  Share Type: A Gu Closely Held Shares: N/A
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.